Scarica l'app Stockscreener
12.34
0.65%
0.08
Dopo l'orario di chiusura:
12.95
0.61
+4.94%
Mbx Biosciences Inc Borsa (MBX) Ultime notizie
The Future of MBX Biosciences Inc: Analyzing MBX - The InvestChronicle
P. Kent Hawryluk Acquires 50,000 Shares of MBX Biosciences, Inc. (NYSE:MBX) Stock - MarketBeat
MBX Biosciences Director Makes Bold Stock Move - TipRanks
MBX Biosciences to Participate in Upcoming February Investor Conferences - The Manila Times
MBX Biosciences CEO to Present at Three Major Healthcare Investor Conferences in February - StockTitan
16,400 Shares in MBX Biosciences, Inc. (NYSE:MBX) Purchased by Barclays PLC - Defense World
Geode Capital Management LLC Invests $579,000 in MBX Biosciences, Inc. (NYSE:MBX) - Defense World
Long-acting MBX 2109 may offer more convenient symptom relief - Hypoparathyroidism News
Early success for MBX in Phase I trial of GLP-1RA for hypoglycaemia - Yahoo Finance
MBX Biosciences' Investigational Drug For Weight Loss Surgery-Related Low Blood Sugar Shows Encouraging Action - AOL
MBX Biosciences (NYSE:MBX) Shares Gap DownTime to Sell? - MarketBeat
MBX 1416 shows promise in Phase 1 trial for hypoglycemia treatment - Investing.com India
MBX Biosciences Announces Positive Phase 1 Topline Results for MBX 1416 for the Treatment of Post-bariatric Hypoglycemia - The Manila Times
MBX Biosciences Announces Positive Phase 1 Topline Results - GlobeNewswire
MBX Biosciences' Long-Acting GLP-1 Drug Shows Promise in Phase 1 Trial with Weekly Dosing - StockTitan
Barclays PLC Buys Shares of 16,400 MBX Biosciences, Inc. (NYSE:MBX) - Defense World
Jane Street Group LLC Makes New $690,000 Investment in MBX Biosciences, Inc. (NYSE:MBX) - Defense World
MBX Biosciences (NYSE:MBX) Trading Down 6.6%Time to Sell? - MarketBeat
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Biotech IPO Shares 2025 Climb In Trading Debuts After Deals Upsized - Browvopetshop
MBX Biosciences (NYSE:MBX) Stock Price Down 7.3%Time to Sell? - MarketBeat
MBX Biosciences (NYSE:MBX) Shares Gap Down – Should You Sell? - Defense World
Franklin Resources Inc. Invests $11.69 Million in MBX Biosciences, Inc. (NYSE:MBX) - MarketBeat
Teachers Retirement System of The State of Kentucky Makes New $694,000 Investment in MBX Biosciences, Inc. (NYSE:MBX) - MarketBeat
MBX Biosciences to Participate in 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
MBX Biosciences (NYSE:MBX) Trading 4.6% HigherHere's Why - MarketBeat
MBX Biosciences (NYSE:MBX) Shares Gap UpWhat's Next? - MarketBeat
The Manufacturers Life Insurance Company Invests $1.20 Million in MBX Biosciences, Inc. (NYSE:MBX) - MarketBeat
Wellington Management Group LLP Takes $74.26 Million Position in MBX Biosciences, Inc. (NYSE:MBX) - MarketBeat
Frazier Life Sciences Management L.P. Makes New $155.50 Million Investment in MBX Biosciences, Inc. (NYSE:MBX) - MarketBeat
Maven Securities LTD Makes New $1.30 Million Investment in MBX Biosciences, Inc. (NYSE:MBX) - MarketBeat
RA Capital Management L.P. Takes $39.26 Million Position in MBX Biosciences, Inc. (NYSE:MBX) - MarketBeat
MBX Biosciences Announces MBX 2109 Phase 1 Study Results Published in The Journal of Clinical Endocrinology and Metabolism - The Manila Times
MBX Biosciences Announces MBX 2109 Phase 1 Study Results - GlobeNewswire
NEA Management Company LLC Invests $93.90 Million in MBX Biosciences, Inc. (NYSE:MBX) - MarketBeat
MBX Biosciences (NYSE:MBX) Shares Down 3.6% – Should You Sell? - Defense World
MBX Biosciences (NYSE:MBX) Shares Down 3.6%Time to Sell? - MarketBeat
MBX Biosciences (NYSE:MBX) Trading Up 6.5%Still a Buy? - MarketBeat
MBX Biosciences completes phase 1 trial of diabetes drug By Investing.com - Investing.com Canada
MBX Biosciences completes phase 1 trial of diabetes drug - Investing.com India
1.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):